Vimarsana
Biggest News Aggregation in the World

Page 2 - Project Lucy News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Project Lucy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Project Lucy Today - Breaking & Trending Today

Psychedelic Research Studies to Watch | Clinical Trials and More - Vimarsana News

Psychedelic Research Studies to Watch | Clinical Trials and More

INN takes a closer look at some of the biggest ongoing psychedelic research studies that could shape the future of the industry. The psychedelics investment proposition is an enticing one for investors, and the bedrock of the industry is the potential attached to clinical research on psychedelic substances. Thanks to the groundbreaking progress of studies and trials evaluating psychedelic treatments, the entire sector is gaining more attention as a new age of medicine becomes a very real possibility. Here the Investing News Network presents some of the biggest psychedelic research studies bei...

Ceres Acquisition (CERAF), COMP SERVICES (CMPS), CURALEAF HLDGS INC by Curaleaf Hldgs Inc. (CURLF), MIND MEDICINE MINDMED by MIND MEDICINE MINDMED INC. (MMEDF), RED LIGHT HOLLAND CORP by Red Light Holland Corp. (TRUFF) - Cannabis Countdown: Top 10 Marijuana And Psychedelic Stock News Stories Of The Week - Vimarsana News

Ceres Acquisition (CERAF), COMP SERVICES (CMPS), CURALEAF HLDGS INC by Curaleaf Hldgs Inc. (CURLF), MIND MEDICINE MINDMED by MIND MEDICINE MINDMED INC. (MMEDF), RED LIGHT HOLLAND CORP by Red Light Holland Corp. (TRUFF) - Cannabis Countdown: Top 10 Marijuana And Psychedelic Stock News Stories Of The Week

Horizons ETFs Made Waves When They Launched the World’s First Psychedelics Stock ETF on the NEO Exchange Early This Year The Dales Report sat down with Steve Hawkins, the President and CEO of Horizons ETFs for an interview, to learn a little bit more about the behind-the-scenes on creating a Psychedelics ETF like  Horizons Psychedelic Stock Index ETF (NEO: PSYK) from scratch, what investors should know, and where the Psychedelics industry – and others – might be headed. Right now, Hawkings says, the psychedelics industry resembles Cannabis in capital market structure. There’s ...

MindMed's LSD Neutralizer Study Begins - Vimarsana News

MindMed's LSD Neutralizer Study Begins

/PRNewswire/ -- MindMed (NEO: MMED), (OTCQB: MMEDF), (DE: MMQ), a leading psychedelic medicine biotech company, announced the start of a study for its LSD...

MindMed Adds Chief Development Officer with FDA Phase 2 Psilocybin Clinical Trial Experience - Vimarsana News

MindMed Adds Chief Development Officer with FDA Phase 2 Psilocybin Clinical Trial Experience

MindMed Adds Chief Development Officer with FDA Phase 2 Psilocybin Clinical Trial Experience News provided by Share this article Psychedelic Pharmaceutical Scientist and Clinical Pharmacologist Robert Barrow Appointed as Chief Development Officer NEW YORK, Jan. 14, 2021 /PRNewswire/ -- MindMed (NEO: MMED), (OTCQB: MMEDF), (DE: MMQ), a leading psychedelic medicine biotech company today announced the addition of Robert Barrow, an accomplished pharmaceutical executive, as Chief Development Officer. Mr. Barrow has over a decade of experience leading drug development programs aimed at identifying...

Up 1,130% in 2020, Is MindMed Still a Buy? - Vimarsana News

Up 1,130% in 2020, Is MindMed Still a Buy?

Author Bio Alex began writing for the Fool in early 2020 and follows companies in the healthcare sector. Formerly a researcher in the biotech industry, he leverages his science background in his work as a writer and entrepreneur. His interests include exploring his hometown of Boston, traveling in Latin America, and value investing. Follow @alexcarchidi If you've ever struggled with anxiety, depression, addiction, or trauma, you know that securing your peace of mind is hard work. And the treatments currently available for those conditions don't suffice for ...

Source: fool.com